REC-01
Hypophosphatasia (HPP)
Phase 1/2aActive
Key Facts
About PuREC
PuREC develops purified mesenchymal stem cell therapies for bone regeneration using its proprietary Rapidly-Expanding Cell (REC) platform.
View full company profileTherapeutic Areas
Other Hypophosphatasia (HPP) Drugs
| Drug | Company | Phase |
|---|---|---|
| OC-1/ALE1 | 1cBio | Phase 1/2a |
| ALE1 | Alesta Therapeutics | Pre-clinical |